Andrew Dreyfus
Board Member
Alto Neuroscience, Inc. (ANRO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Andrew Dreyfus
Andrew Dreyfus is recorded as Board Member at Alto Neuroscience, Inc. (ANRO). Ironwood Pharmaceuticals Inc reported in an 8-K filed October 10, 2025 that Andrew Dreyfus resigned as Board of Directors, effective November 1, 2025. Alto Neuroscience, Inc. reported in an 8-K filed August 13, 2025 that Andrew Dreyfus was appointed Class I director, effective August 12, 2025. Alto Neuroscience, Inc. reported in an 8-K filed August 13, 2025 that Andrew Dreyfus resigned as Class III director, effective August 12, 2025.
“On October 7, 2025, Andrew Dreyfus provided notice of his resignation from the Board of Directors of Ironwood Pharmaceuticals, Inc. (the "Company"), effective November 1, 2025.”
“Immediately following such resignations, the Board appointed Messrs. Dreyfus and Cox as Class I and Class III directors, respectively.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-08-12–present
-
Start not stated–2025-08-12
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Alto Neuroscience, Inc.
Other people whose current roles at this company are on record from its filings.
- Amit Etkin CEO, Board Member
- Nicholas Smith CFO
- Michael Hanley COO
- Andrew Miller, Ph.D. Board Member
- Christopher Nixon Cox Board Member
- Gwill York Board Member
- Husseini Manji Board Member
- Maha Radhakrishnan, M.D. Board Member
- Ramiro (Raymond) Sanchez, M.D. Board Member
- Raymond Sanchez Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.